cubistpharmaceuticalsinc

CubistPharmaceuticalsInc.(Nasdaq:CBST);Product,Industry,anti-infectivedrug;Street,65HaydenAvenue;City,02421Lexington,MA;Tel,+1-781-860-8660.,CubistPharmaceuticalsLLCoperatesasapharmaceuticalcompany.TheCompanyfocusesonresearch,development,andcommercializationofpharmaceutical ...,2016年7月25日—CubistPharmaceuticals,Inc.從事新型抗微生物的藥品研發、產銷，所產...公司於2013年9月收購抗生素開發公司Tri...

參考資訊如下
Cubist Pharmaceuticals Inc. (Nasdaq

Cubist Pharmaceuticals Inc. (Nasdaq: CBST) ; Product, Industry, anti-infective drug ; Street, 65 Hayden Avenue ; City, 02421 Lexington, MA ; Tel, +1-781-860-8660.

Cubist Pharmaceuticals LLC

Cubist Pharmaceuticals LLC operates as a pharmaceutical company. The Company focuses on research, development, and commercialization of pharmaceutical ...

立體派製藥公司(CBST.US)

2016年7月25日 — Cubist Pharmaceuticals, Inc. 從事新型抗微生物的藥品研發、產銷，所產 ... 公司於2013年9月收購抗生素開發公司Trius Therapeutics, Inc.。 公司於 ...

說明

Merck to Acquire Cubist Pharmaceuticals for $102 Per ...

2014年12月8日 — Merck to Acquire Cubist Pharmaceuticals for $102 Per Share in Cash. Save. December 8, 2014 7:00 am ET. Acquisition Augments Merck's Strong ...

Cubist Pharmaceuticals

Cubist Pharmaceuticals was an American biopharmaceutical company that targeted pathogens like MRSA. Cubist Pharmaceuticals, INC ...

Cubist Pharmaceuticals

Cubist Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the research, development, and commercialization of.

Cubist Pharmaceuticals, Inc. - Product Pipeline Review

2014年5月21日 — This report provides comprehensive information on the current therapeutic developmental pipeline of Cubist Pharmaceuticals, Inc.'s, complete ...